about
Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabul...
Read More
2.32
-0.09
(-3.73%)
85,802.5
XNAS Volume
XNAS 18 Mar, 2026 3:14 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Veru Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..